Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 121

1.

Resveratrol as a therapeutic agent for neurodegenerative diseases.

Sun AY, Wang Q, Simonyi A, Sun GY.

Mol Neurobiol. 2010 Jun;41(2-3):375-83. doi: 10.1007/s12035-010-8111-y. Review.

2.

Botanical phenolics and brain health.

Sun AY, Wang Q, Simonyi A, Sun GY.

Neuromolecular Med. 2008;10(4):259-74. doi: 10.1007/s12017-008-8052-z. Review.

3.

Mitochondrial biogenesis: pharmacological approaches.

Valero T.

Curr Pharm Des. 2014;20(35):5507-9.

PMID:
24606795
4.
5.

Resveratrol and stroke: from chemistry to medicine.

Nabavi SF, Li H, Daglia M, Nabavi SM.

Curr Neurovasc Res. 2014;11(4):390-7. Review.

PMID:
25219659
6.

Oxidative stress, mitochondrial dysfunction and cellular stress response in Friedreich's ataxia.

Calabrese V, Lodi R, Tonon C, D'Agata V, Sapienza M, Scapagnini G, Mangiameli A, Pennisi G, Stella AM, Butterfield DA.

J Neurol Sci. 2005 Jun 15;233(1-2):145-62. Review.

PMID:
15896810
7.

Ageing and neurodegenerative diseases.

Hung CW, Chen YC, Hsieh WL, Chiou SH, Kao CL.

Ageing Res Rev. 2010 Nov;9 Suppl 1:S36-46. doi: 10.1016/j.arr.2010.08.006. Review.

PMID:
20732460
8.

Vasoprotective effects of resveratrol and SIRT1: attenuation of cigarette smoke-induced oxidative stress and proinflammatory phenotypic alterations.

Csiszar A, Labinskyy N, Podlutsky A, Kaminski PM, Wolin MS, Zhang C, Mukhopadhyay P, Pacher P, Hu F, de Cabo R, Ballabh P, Ungvari Z.

Am J Physiol Heart Circ Physiol. 2008 Jun;294(6):H2721-35. doi: 10.1152/ajpheart.00235.2008.

10.

Oxidative stress, antioxidants and neurodegenerative diseases.

Casetta I, Govoni V, Granieri E.

Curr Pharm Des. 2005;11(16):2033-52. Review.

PMID:
15974957
11.

Resveratrol attenuates 6-hydroxydopamine-induced oxidative damage and dopamine depletion in rat model of Parkinson's disease.

Khan MM, Ahmad A, Ishrat T, Khan MB, Hoda MN, Khuwaja G, Raza SS, Khan A, Javed H, Vaibhav K, Islam F.

Brain Res. 2010 Apr 30;1328:139-51. doi: 10.1016/j.brainres.2010.02.031.

PMID:
20167206
12.

Resveratrol and neurodegenerative diseases: activation of SIRT1 as the potential pathway towards neuroprotection.

Pallàs M, Casadesús G, Smith MA, Coto-Montes A, Pelegri C, Vilaplana J, Camins A.

Curr Neurovasc Res. 2009 Feb;6(1):70-81. Review.

PMID:
19355928
13.

Resveratrol protects dopamine neurons against lipopolysaccharide-induced neurotoxicity through its anti-inflammatory actions.

Zhang F, Shi JS, Zhou H, Wilson B, Hong JS, Gao HM.

Mol Pharmacol. 2010 Sep;78(3):466-77. doi: 10.1124/mol.110.064535. Erratum in: Mol Pharmacol. 2010 Nov;78(5):981.

14.

Resveratrol as a therapeutic agent for Alzheimer's disease.

Ma T, Tan MS, Yu JT, Tan L.

Biomed Res Int. 2014;2014:350516. doi: 10.1155/2014/350516. Review.

15.

Beneficial effects of resveratrol on atherosclerosis.

Fan E, Zhang L, Jiang S, Bai Y.

J Med Food. 2008 Dec;11(4):610-4. doi: 10.1089/jmf.2007.0091. Review.

PMID:
19053850
16.

Oxidative nerve cell death in Alzheimer's disease and stroke: antioxidants as neuroprotective compounds.

Behl C, Moosmann B.

Biol Chem. 2002 Mar-Apr;383(3-4):521-36. Review.

PMID:
12033440
17.

Neuroprotective properties of resveratrol in different neurodegenerative disorders.

Albani D, Polito L, Signorini A, Forloni G.

Biofactors. 2010 Sep-Oct;36(5):370-6. doi: 10.1002/biof.118. Review.

PMID:
20848560
18.

Resveratrol--a boon for treating Alzheimer's disease?

Anekonda TS.

Brain Res Rev. 2006 Sep;52(2):316-26. Review.

PMID:
16766037
19.

[Resveratrol: a neuroprotective polyphenol in the Mediterranean diet].

López-Miranda V, Soto-Montenegro ML, Vera G, Herradón E, Desco M, Abalo R.

Rev Neurol. 2012 Mar 16;54(6):349-56. Review. Spanish.

20.

Nutraceutical antioxidants as novel neuroprotective agents.

Kelsey NA, Wilkins HM, Linseman DA.

Molecules. 2010 Nov 3;15(11):7792-814. doi: 10.3390/molecules15117792. Review.

Supplemental Content

Support Center